Skip to main content
The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
0.235
-0.029 (-10.84%)
At close: Nov 14, 2024, 4:00 PM
0.260
+0.025 (10.54%)
After-hours: Nov 14, 2024, 7:58 PM EST

The Oncology Institute Revenue

The Oncology Institute had revenue of $99.90M in the quarter ending September 30, 2024, with 21.78% growth. This brings the company's revenue in the last twelve months to $378.93M, up 22.29% year-over-year. In the year 2023, The Oncology Institute had annual revenue of $324.24M with 28.42% growth.

Revenue (ttm)
$378.93M
Revenue Growth
+22.29%
P/S Ratio
0.05
Revenue / Employee
$451,334
Employees
800
Market Cap
17.76M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023324.24M71.76M28.42%
Dec 31, 2022252.48M49.48M24.37%
Dec 31, 2021203.00M15.49M8.26%
Dec 31, 2020187.52M32.11M20.66%
Dec 31, 2019155.41M42.25M37.33%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Lifeward 25.00M
Nephros 13.55M
ProPhase Labs 12.75M
Cara Therapeutics 11.00M
Pulmatrix 10.01M
bioAffinity Technologies 7.32M
Aprea Therapeutics 1.31M
Traws Pharma 226.00K
Revenue Rankings

TOI News

More News